Proprietary hardware and software that enables rapid authentication of pharmaceuticals to combat counterfeit medications, using machine learning and molecular spectroscopy. Launched marketplace for authenticated pharmaceuticals for patients and pharmacies
CURRENT PROGRAM
ACTIVELY RAISING
HEALTHCARE
FINTECH
Globally, counterfeit medication kills 1 million people per year. 10% of that in Africa alone. Counterfeiting impacts the full healthcare ecosystem from regulators to pharmacies, and ultimately patients. It is a global problem representing $200 billion across 100 countries.
RxAll is dedicated to providing high quality medication to the patients that need them. The RxScanner is a proprietary molecular sensor device that can identify the quality of prescription drugs in 20 seconds displaying results on an IoS and Android app in real-time.
Drugs that have been authenticated can be bought online by pharmacies and patients for offline delivery through RxDelivered. Pharmacies can access authenticated medication at wholesale prices and increase sales, and patients have better access to high quality medication.
RxAll are looking for partners to assist with their expansion into West Africa and South East Asia.
If you’re an African-focused early-stage investor and interested in participating in RxAll's current funding round
If you’re interested in partnering with RxAll as a healthcare provider, healthcare manufacturer or other value-added partner
